Jason Wood
About Jason Wood
Current Position at Alkermes
Jason Wood is currently employed as an Associate Principal Scientist at Alkermes, located in Waltham, Massachusetts, United States. Alkermes focuses on developing innovative medicines designed to address the unmet needs of patients suffering from serious mental health and neurological diseases. In his role, Jason is engaged in cutting-edge research and development, leveraging his extensive background in biological and biomedical sciences.
Previous Roles at Brown University
Jason Wood has a significant academic and research history at Brown University. He served as an Assistant Professor (Research) from 2019 to 2021 in Providence, Rhode Island Area. Prior to that, he held the position of Investigator from 2011 to 2019. Jason also contributed to the institution's research landscape as a Postdoctoral Fellow from 2006 to 2011. These roles allowed him to deepen his expertise in neurodegeneration and lifespan research.
Educational Background: Harvard Medical School
Jason Wood completed his Doctor of Philosophy (Ph.D.) in Biological and Biomedical Sciences at Harvard Medical School, where he studied from 1999 to 2005. During his Ph.D. studies, he focused on advanced research techniques and methodologies that laid the groundwork for his future research endeavors in mitochondrial metabolism, neurodegeneration, and lifespan.
Educational Background: Harvard University
Jason Wood began his academic journey at Harvard University, where he achieved a Bachelor of Arts (A.B.) in Biochemical Sciences. He studied at the institution from 1993 to 1999. This foundational education equipped him with essential knowledge and skills, enabling him to pursue advanced research and contribute to the biomedical sciences field significantly.
Research Interests and Techniques
Jason Wood's research interests encompass the effects of mitochondrial metabolism on neurodegeneration and lifespan. His work focuses on the transcriptomics and epigenomics of aging and Alzheimer's models, investigating chromatin modification and genomic stability. He utilizes a range of advanced techniques, including bulk and single cell (10x) RNA-seq, ATAC-seq, CUT&RUN, ChIP-seq, and genomic DNA-seq on the Illumina platform. Jason also specializes in multiomic bioinformatic data processing and analysis, which aids in visualizing, understanding, and interpreting complex datasets. His studies extend to small RNA pathways, their impact on longevity, and transposable element silencing mechanisms in the context of aging and neurodegeneration.